1. Home
  2. ADPT vs PCT Comparison

ADPT vs PCT Comparison

Compare ADPT & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$18.46

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$11.64

Market Cap

2.1B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADPT
PCT
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ADPT
PCT
Price
$18.46
$11.64
Analyst Decision
Strong Buy
Buy
Analyst Count
10
3
Target Price
$16.60
$13.67
AVG Volume (30 Days)
1.9M
4.4M
Earning Date
02-05-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$252,754,000.00
$5,660,000.00
Revenue This Year
$50.86
N/A
Revenue Next Year
$0.53
$707.73
P/E Ratio
N/A
N/A
Revenue Growth
42.57
N/A
52 Week Low
$6.26
$5.40
52 Week High
$20.76
$17.37

Technical Indicators

Market Signals
Indicator
ADPT
PCT
Relative Strength Index (RSI) 59.49 63.73
Support Level $16.55 $10.79
Resistance Level $19.16 $12.31
Average True Range (ATR) 1.00 0.78
MACD 0.18 0.21
Stochastic Oscillator 82.08 80.81

Price Performance

Historical Comparison
ADPT
PCT

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Share on Social Networks: